A Study on Intestinal Gas Symptoms to Evaluate the Effects of Gas Defense in Otherwise Healthy Adult

Inclusion Criteria: * Subject is 18-75 years of age. * Subject self-reports at least one of the following symptoms after eating a meal or snack: * Abdominal pain/cramps * Distended feeling/bloating * Flatulence/gas * Subject is in otherwise general good health as determined by physical exam and medical history. * Subject is willing and able to comply with the protocol. * Female subjects not defined as post-menopausal (excluding hysterectomized and post bilateral tubal ligations) must use a reliable method of birth control as defined within this protocol. * Subject is able to understand and sign the informed consent (English or Spanish) to participate in the study. Exclusion Criteria: * Subject has any of the following medical conditions: * active heart disease * renal or hepatic impairment/disease * Type I or II diabetes * psychiatric disorders (hospitalized within the past one year) * bipolar disorder * Parkinson's disease * unstable thyroid disease * immune disorder (such as HIV/AIDS) * any medical condition deemed exclusionary by the Principal Investigator (PI) * Subject has a history of cancer (except localized skin cancer without metastases or in situ cervical cancer) within five years prior to screening. * Subject has had any stomach or intestinal surgery (i.e. gastric bypass). * Subject is currently taking antibiotics (or any drug that significantly interferes with bacterial flora) or has taken antibiotics within the 30 days prior to screening/enrollment. * Subject is currently taking or has used in the past 30 days probiotics or prebiotics. * Subject is on an unstable dose of medication (defined as fewer than 90 days at the same dose). * Subject is currently taking any medication deemed exclusionary by PI. * Subject has a history of or currently has any gastrointestinal disorders or inflammatory bowel conditions such as Crohn's disease, short bowel, or ulcerative colitis. Subjects may not have a diagnosis, be seeing a doctor, or taking prescription medication(s) for Irritable Bowel Syndrome (IBS). * Subject has constipation defined as less than three spontaneous bowel movements per week. * Subject is lactose intolerant (self-professed or diagnosed). * Subject uses any of the following classification of GI medications two or more times per week: anti-spasmodics, motility agents, pro-kinetic agents or laxatives. * Subject plans to use another over-the-counter gas-relief product daily during the study period. Over-the-counter gas relief products may be used as rescue medication (their use will be captured by the study staff). If a subject is using a fiber supplement prior to starting the study, he/she may continue as long as the frequency and quantity remain stable throughout the study period. * Subject has an allergy to wheat or fish or any of the other product ingredients (see section 2.5.4). * Subject has two or more food allergies. * Subject has a history of drug or alcohol abuse within the past 12 months. * Subject is deemed by the Investigator as an unsuitable candidate for receipt of an investigational dietary supplement, or unable to be followed up throughout the entire duration of the study. * Female subject of childbearing potential is unwilling to use an acceptable form of contraceptive device throughout the study period. * Subject is pregnant, lactating, or planning to become pregnant during the study period. * Subject is participating in another clinical trial or has received an investigational product within 30 days prior to screening/enrollment. * Subject is deemed by the Investigator as an unsuitable candidate for receipt of an investigational dietary supplement, or unable to be followed up throughout the entire duration of the study. * Subject is unable to comprehend the Informed Consent and research purpose. * Subject is unable or unwilling to comply with the protocol.